Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases. (PubMed, Inflamm Res) - Jun 9, 2026 - "FcRn blockade represents a promising precision-medicine strategy for IgG-driven AIIRD. Future studies should define optimal patient populations, identify predictive biomarkers, optimize next-generation molecules, and clarify long-term safety, pharmacoeconomic value, and opportunities for indication expansion."
Journal • Review • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Myositis • Rheumatoid Arthritis • Rheumatology • Sjogren's Syndrome • Systemic Lupus Erythematosus
|
|
Lingli Dong; Peixuan Liang; Shaozhe Cai; Wei Sun
|